132 related articles for article (PubMed ID: 34795031)
1. Prevalence of systemic lupus erythematosus-related symptoms assessed by using the Connective Tissue Disease Screening Questionnaire in a large population-based cohort.
Lambers W; Arends S; Roozendaal C; Brouwer E; Bootsma H; Westra J; de Leeuw K
Lupus Sci Med; 2021 Nov; 8(1):. PubMed ID: 34795031
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the Connective Tissue Screening Questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus.
Farrell MS; Wallace SJ; Clarke SM; Tarafder MR; McLaughlin WA
J Prim Care Community Health; 2014 Apr; 5(2):134-8. PubMed ID: 24327597
[TBL] [Abstract][Full Text] [Related]
3. Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.
Munroe ME; Young KA; Kamen DL; Guthridge JM; Niewold TB; Costenbader KH; Weisman MH; Ishimori ML; Wallace DJ; Gilkeson GS; Karp DR; Harley JB; Norris JM; James JA
Arthritis Rheumatol; 2017 Mar; 69(3):630-642. PubMed ID: 27863174
[TBL] [Abstract][Full Text] [Related]
4. Cross-cultural adaptation of the connective tissue disease screening questionnaire and development of a Chinese version in a multi-ethnic Asian population.
Xiang L; Teo EPS; Low AHL; Leung YY; Fong W; Xin X; Gandhi M; Kwan YH; Uy EJB; Sparks JA; Karlson EW; Thumboo J
Clin Rheumatol; 2019 Sep; 38(9):2383-2397. PubMed ID: 31037459
[TBL] [Abstract][Full Text] [Related]
5. Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.
Munroe ME; Young KA; Guthridge JM; Kamen DL; Gilkeson GS; Weisman MH; Ishimori ML; Wallace DJ; Karp DR; Harley JB; Norris JM; James JA
Front Immunol; 2022; 13():866181. PubMed ID: 35720322
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women.
Karlson EW; Costenbader KH; McAlindon TE; Massarotti EM; Fitzgerald LM; Jajoo R; Husni E; Wright EA; Pankey H; Fraser PA
Lupus; 2005; 14(10):832-6. PubMed ID: 16304727
[TBL] [Abstract][Full Text] [Related]
7. Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE.
Young KA; Munroe ME; Guthridge JM; Kamen DL; Gilkensen GS; Harley JB; Weisman MH; Karp DR; Wallace DJ; James JA; Norris JM
Lupus; 2019 Apr; 28(5):597-606. PubMed ID: 30845880
[TBL] [Abstract][Full Text] [Related]
8. Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression.
Liang E; Taylor M; McMahon M
Lupus Sci Med; 2020; 7(1):e000345. PubMed ID: 32231785
[TBL] [Abstract][Full Text] [Related]
9. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
10. Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease.
Radin M; Schreiber K; Cecchi I; Bortoluzzi A; Crisafulli F; de Freitas CM; Bacco B; Rubini E; Foddai SG; Padovan M; Gallo Cassarino S; Franceschini F; Andrade D; Benedetto C; Govoni M; Bertero T; Marozio L; Roccatello D; Andreoli L; Sciascia S
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1804-1808. PubMed ID: 32702197
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
12. Improving sensitivity of the connective tissue disease screening questionnaire: A comparative study of various scoring methods.
Xiang L; Low AHL; Leung YY; Fong W; Gandhi M; Xin X; Uy EJ; Sparks JA; Karlson EW; Thumboo J
Lupus; 2021 Jan; 30(1):35-44. PubMed ID: 33092467
[TBL] [Abstract][Full Text] [Related]
13. Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease.
Erden A; Apaydın H; Fanouriakis A; Güven SC; Armagan B; Akyüz Dağlı P; Konak HE; Polat B; Atalar E; Esmer S; Karakaş Ö; Özdemir B; Eksin MA; Omma A; Kücüksahin O; Bertsias GK; Boumpas DT
Rheumatology (Oxford); 2022 Aug; 61(9):3606-3613. PubMed ID: 35015853
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
Aberle T; Bourn RL; Munroe ME; Chen H; Roberts VC; Guthridge JM; Bean K; Robertson JM; Sivils KL; Rasmussen A; Liles M; Merrill JT; Harley JB; Olsen NJ; Karp DR; James JA
Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1780-1788. PubMed ID: 28118528
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters.
Cafaro G; Bartoloni E; Baldini C; Franceschini F; Riccieri V; Fioravanti A; Fornaro M; Ghirardello A; Palterer B; Infantino M; Rigon A; Del Rosso S; Gerli R; Villalta D; Bizzaro N; ;
RMD Open; 2023 Sep; 9(3):. PubMed ID: 37734871
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
17. Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients.
Leuchten N; Milke B; Winkler-Rohlfing B; Daikh D; Dörner T; Johnson SR; Aringer M;
Lupus; 2018 Aug; 27(9):1431-1436. PubMed ID: 29771193
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Quality of Life (QoL) in Systemic Lupus Erythematosus Patients at a Tertiary Care Hospital in Egypt.
Behiry ME; Ahmed SA; Elsebaie EH
Curr Rheumatol Rev; 2019; 15(4):304-311. PubMed ID: 30657042
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anti-rheumatoid arthritis 33 antibody in patients with systemic lupus erythematosus.
Lu WY; Hong XP; Xie JY; Liu CL; Chen CH; Qin-Huang ; Sun BD; Liu DZ; Chen YL
J Investig Med; 2023 Apr; 71(4):429-438. PubMed ID: 36695444
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.
Michet CJ; McKenna CH; Elveback LR; Kaslow RA; Kurland LT
Mayo Clin Proc; 1985 Feb; 60(2):105-13. PubMed ID: 3974288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
